{"id":"W2898630421","doi":"10.1182/blood-2018-99-116653","title":"Ibrutinib Alone or in Combination with Rituximab Produces Superior Progression Free Survival (PFS) Compared with Bendamustine Plus Rituximab in Untreated Older Patients with Chronic Lymphocytic Leukemia (CLL): Results of Alliance North American Intergroup Study A041202","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Bendamustine; Ibrutinib; Rituximab; Chronic lymphocytic leukemia; Medicine; Alemtuzumab; Internal medicine; Progression-free survival; Ofatumumab; Oncology; Leukemia; Chemotherapy; Lymphoma; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001909143,0.0005726937,0.0009747572,0.0003418644,0.0002342968,0.000698226,0.0004234526,0.0006633925,0.00216858],"category_scores_gemma":[0.00134546,0.0002602855,0.001187318,0.000348177,0.0003026755,0.0006036524,0.0003137134,0.001307176,0.000467883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004267561,"about_ca_system_score_gemma":0.0004576321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006160388,"about_ca_topic_score_gemma":0.001163458,"domain_scores_codex":[0.9994707,0.0002867462,0.000042394,0.00008986081,0.00005692335,0.00005339468],"domain_scores_gemma":[0.9990894,0.0002249169,0.0002485852,0.00009207991,0.00005099229,0.0002941638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7942937,0.02834896,0.03772504,0.0005557618,0.003076846,0.000169653,0.0003484073,0.001530554,0.02861418,0.00007623655,0.002769464,0.1024911],"study_design_scores_gemma":[0.1504875,0.6837311,0.152819,0.00007850221,0.002513969,0.0003837719,0.0001233643,0.001376207,0.003994027,0.0002039784,0.004229615,0.00005887511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972435,0.001604023,0.00005589927,0.0001169501,0.00004777567,0.00007860982,0.0003603634,0.000017583,0.0004751229],"genre_scores_gemma":[0.9974735,0.0006870086,0.0001488844,0.0002574035,0.0001364428,0.00009735513,0.0006886804,0.000007508282,0.000503176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00216858,"threshold_uncertainty_score":0.01009661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01508836516156946,"score_gpt":0.283212304798396,"score_spread":0.2681239396368266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}